Durst Christopher R, Raghavan Prashant, Shaffrey Mark E, Schiff David, Lopes M Beatriz, Sheehan Jason P, Tustison Nicholas J, Patrie James T, Xin Wenjun, Elias W Jeff, Liu Kenneth C, Helm Greg A, Cupino A, Wintermark Max
University of Virginia Health Systems, Division of Neuroradiology, Department of Radiology and Medical Imaging, PO Box 800170, FedEx:1215 Lee Street-New Hospital, Charlottesville, VA, 22908, USA,
Neuroradiology. 2014 Feb;56(2):107-15. doi: 10.1007/s00234-013-1308-9. Epub 2013 Dec 15.
Gliomas remain difficult to treat, in part, due to our inability to accurately delineate the margins of the tumor. The goal of our study was to evaluate if a combination of advanced MR imaging techniques and a multimodal imaging model could be used to predict tumor infiltration in patients with diffuse gliomas.
Institutional review board approval and written consent were obtained. This prospective pilot study enrolled patients undergoing stereotactic biopsy for a suspected de novo glioma. Stereotactic biopsy coordinates were coregistered with multiple standard and advanced neuroimaging sequences in 10 patients. Objective imaging values were assigned to the biopsy sites for each of the imaging sequences. A principal component analysis was performed to reduce the dimensionality of the imaging dataset without losing important information. A univariate analysis was performed to identify the statistically relevant principal components. Finally, a multivariate analysis was used to build the final model describing nuclear density.
A univariate analysis identified three principal components as being linearly associated with the observed nuclear density (p values 0.021, 0.016, and 0.046, respectively). These three principal component composite scores are predominantly comprised of DTI (mean diffusivity or average diffusion coefficient and fractional anisotropy) and PWI data (rMTT, Ktrans). The p value of the model was <0.001. The correlation between the predicted and observed nuclear density was 0.75.
A multi-input, single output imaging model may predict the extent of glioma invasion with significant correlation with histopathology.
胶质瘤仍然难以治疗,部分原因是我们无法准确勾勒肿瘤边界。我们研究的目的是评估先进的磁共振成像技术和多模态成像模型的组合是否可用于预测弥漫性胶质瘤患者的肿瘤浸润情况。
获得了机构审查委员会的批准和书面同意。这项前瞻性试点研究纳入了因疑似原发性胶质瘤而接受立体定向活检的患者。在10名患者中,将立体定向活检坐标与多个标准和先进的神经影像序列进行了配准。为每个影像序列的活检部位分配了客观影像值。进行主成分分析以降低影像数据集的维度,同时不丢失重要信息。进行单变量分析以识别具有统计学相关性的主成分。最后,使用多变量分析构建描述核密度的最终模型。
单变量分析确定了三个与观察到的核密度呈线性相关的主成分(p值分别为0.021、0.016和0.046)。这三个主成分综合评分主要由扩散张量成像(平均扩散率或平均扩散系数以及分数各向异性)和灌注加权成像数据(相对平均通过时间、容积转移常数)组成。该模型的p值<0.001。预测的核密度与观察到的核密度之间的相关性为0.75。
一个多输入、单输出的成像模型可能预测胶质瘤浸润范围,且与组织病理学具有显著相关性。